Yokokawa F - Search Results

1

The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons.

LePage KT, Goeger D, Yokokawa F, Asano T, Shioiri T, Gerwick WH, Murray TF. LePage KT, et al. Among authors: yokokawa f. Toxicol Lett. 2005 Aug 14;158(2):133-9. doi: 10.1016/j.toxlet.2005.03.007. Epub 2005 Apr 9. Toxicol Lett. 2005. PMID: 16039402

2

Antillatoxin is a marine cyanobacterial toxin that potently activates voltage-gated sodium channels.

Li WI, Berman FW, Okino T, Yokokawa F, Shioiri T, Gerwick WH, Murray TF. Li WI, et al. Among authors: yokokawa f. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7599-604. doi: 10.1073/pnas.121085898. Proc Natl Acad Sci U S A. 2001. PMID: 11416227 Free PMC article.

3

Characterization of the preferred stereochemistry for the neuropharmacologic actions of antillatoxin.

Li WI, Marquez BL, Okino T, Yokokawa F, Shioiri T, Gerwick WH, Murray TF. Li WI, et al. Among authors: yokokawa f. J Nat Prod. 2004 Apr;67(4):559-68. doi: 10.1021/np0303409. J Nat Prod. 2004. PMID: 15104484

4

Total synthesis of the antiviral marine natural product (-)-hennoxazole A.

Yokokawa F, Asano T, Shioiri T. Yokokawa F, et al. Org Lett. 2000 Dec 28;2(26):4169-72. doi: 10.1021/ol000305i. Org Lett. 2000. PMID: 11150191

5

Asymmetric total synthesis of (-)-mycothiazole.

Sugiyama H, Yokokawa F, Shioiri T. Sugiyama H, et al. Among authors: yokokawa f. Org Lett. 2000 Jul 13;2(14):2149-52. doi: 10.1021/ol000128l. Org Lett. 2000. PMID: 10891253

6

Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-cyanopyrimidines. Part 2.

Irie O, Kosaka T, Kishida M, Sakaki J, Masuya K, Konishi K, Yokokawa F, Ehara T, Iwasaki A, Iwaki Y, Hitomi Y, Toyao A, Gunji H, Teno N, Iwasaki G, Hirao H, Kanazawa T, Tanabe K, Hiestand PC, Malcangio M, Fox AJ, Bevan SJ, Yaqoob M, Culshaw AJ, Hart TW, Hallett A. Irie O, et al. Among authors: yokokawa f. Bioorg Med Chem Lett. 2008 Oct 1;18(19):5280-4. doi: 10.1016/j.bmcl.2008.08.067. Epub 2008 Aug 22. Bioorg Med Chem Lett. 2008. PMID: 18783943

7

Synthesis and antiviral activity of 4,6-disubstituted pyrimido[4,5-b]indole ribonucleosides.

Tichý M, Pohl R, Xu HY, Chen YL, Yokokawa F, Shi PY, Hocek M. Tichý M, et al. Among authors: yokokawa f. Bioorg Med Chem. 2012 Oct 15;20(20):6123-33. doi: 10.1016/j.bmc.2012.08.021. Epub 2012 Aug 24. Bioorg Med Chem. 2012. PMID: 22985963

8

A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.

Rice RL, Rusnak JM, Yokokawa F, Yokokawa S, Messner DJ, Boynton AL, Wipf P, Lazo JS. Rice RL, et al. Among authors: yokokawa s, yokokawa f. Biochemistry. 1997 Dec 16;36(50):15965-74. doi: 10.1021/bi971338h. Biochemistry. 1997. PMID: 9398331

9

Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-alphaalphadelta9, a novel small molecule antisignaling agent identified in a targeted array library.

Vogt A, Rice RL, Settineri CE, Yokokawa F, Yokokawa S, Wipf P, Lazo JS. Vogt A, et al. Among authors: yokokawa s, yokokawa f. J Pharmacol Exp Ther. 1998 Nov;287(2):806-13. J Pharmacol Exp Ther. 1998. PMID: 9808713

10

Discovery of selective and nonpeptidic cathepsin S inhibitors.

Irie O, Ehara T, Iwasaki A, Yokokawa F, Sakaki J, Hirao H, Kanazawa T, Teno N, Horiuchi M, Umemura I, Gunji H, Masuya K, Hitomi Y, Iwasaki G, Nonomura K, Tanabe K, Fukaya H, Kosaka T, Snell CR, Hallett A. Irie O, et al. Among authors: yokokawa f. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3959-62. doi: 10.1016/j.bmcl.2008.06.009. Epub 2008 Jun 10. Bioorg Med Chem Lett. 2008. PMID: 18572405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page